Search Results - "SHAH, Niraj James"

Refine Results
  1. 1

    Effects of triple-drug therapy with nitazoxanide, high-dose ribavirin and peginterferon-α-2a in patients with chronic hepatitis C by Basu, P. Patrick, Rayapudi, Krishna, Shah, Niraj James, Krishnaswamy, Nithya, Brown, Robert S.

    Published in Hepatology research (01-06-2013)
    “…Aim The historical standard of care for patients with chronic hepatitis C virus (HCV) was peginterferon (PEG IFN) and ribavirin combination therapy, yielding…”
    Get full text
    Journal Article
  2. 2

    A Randomized Study Comparing Levofloxacin, Omeprazole, Nitazoxanide, and Doxycycline versus Triple Therapy for the Eradication of Helicobacter pylori by PATRICK BASU, P, RAYAPUDI, Krishna, PACANA, Tommy, SHAH, Niraj James, KRISHNASWAMY, Nithya, FLYNN, Molly

    Published in The American journal of gastroenterology (01-11-2011)
    “…Resistance to standard Helicobacter pylori (HP) treatment regimens has led to unsatisfactory cure rates in HP-infected patients. This study was designed to…”
    Get full text
    Journal Article
  3. 3

    Epidemiology and outcomes of gastrointestinal mucosal melanomas: a national database analysis by Shah, Niraj James, Aloysius, Mark M, Bhanat, Eldrin, Gupta, Shweta, Aswath, Ganesh, John, Savio, Tang, Shou-Jiang, Goyal, Hemant

    Published in BMC gastroenterology (09-04-2022)
    “…Gastrointestinal malignant melanoma is a rare mucosal melanoma (MM). Other MM include the respiratory and the genitourinary tract. All mucosal melanomas have a…”
    Get full text
    Journal Article
  4. 4

    Clinical and Neurologic Manifestation of Minimal Hepatic Encephalopathy and Overt Hepatic Encephalopathy by Basu, P. Patrick, MD, MRCP, Shah, Niraj James, MD

    Published in Clinics in liver disease (01-08-2015)
    “…Hepatic encephalopathy (HE) shows a wide spectrum of neuropsychiatric manifestations. A combined effort with neuropsychological and psychometric evaluation has…”
    Get full text
    Journal Article
  5. 5

    Is it time to rethink combined liver-kidney transplant in hepatitis C patients with advanced fibrosis? by Shah, Niraj James, Russo, Mark W

    Published in World journal of hepatology (18-02-2017)
    “…AIM To reduce hepatic and extrahepatic complications of chronic hepatitis C in kidney transplant recipients.METHODS We conducted a systematic review of kidney…”
    Get full text
    Journal Article
  6. 6

    Rifaximin therapy for metronidazole-unresponsive Clostridium difficile infection: a prospective pilot trial by Basu, P. Patrick, Dinani, Amreen, Rayapudi, Krishna, Pacana, Tommy, Shah, Niraj James, Hampole, Hemant, Krishnaswamy, N.V., Mohan, Vinod

    Published in Therapeutic advances in gastroenterology (01-07-2010)
    “…Background: Clostridium difficile infection (CDI) is a recent epidemic in the United States, particularly in the hospital setting. Oral metronidazole is…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Demographic profile, management, and survival of primary Gastrointestinal Kaposi Sarcoma: A USA Nationwide SEER-based study by Shah, Niraj James, Aloysius, Mark M., Bhanat, Eldrin, Gupta, Shweta, Savio, John, Aswath, Ganesh, Schafer, David C., Goyal, Hemant

    Published in Cancer epidemiology (01-12-2022)
    “…Kaposi Sarcoma (KS) is a Human Herpes Virus-8 (HHV-8) associated angio-proliferative disorder commonly seen in patients with HIV. It most commonly involves the…”
    Get full text
    Journal Article
  10. 10

    Fibrolamellar hepatocellular carcinoma: An epidemiologic and 5-year cancer survival assessment based off SEER data by Aloysius, Mark M, Iskander, Peter, Ahmed, Khalid, Asija, Udit, Mohammed, Elmkdad, Iskander, Anthony, Shah, Niraj James, Goyal, Hemant, Khurana, Vikas, Simin, Nasr, Aswath, Ganesh, John, Savio

    “…•Fibrolamellar hepatocellular (HCC) carcinoma is a rare subset of liver tumors.•Risks factors and symptoms can vary greatly from classic HCC.•Younger age, male…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Advances in treatment and prevention of hepatitis B by Shah, Niraj James, Aloysius, Mark M, Sharma, Neil Rohit, Pallav, Kumar

    “…Chronic hepatitis B (CHB) continues to contribute to worldwide morbidity and mortality significantly. Scientists, clinicians, pharmaceutical companies, and…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20